Key hire
Azura Ophthalmics Announces Formation of Scientific Advisory Board (SAB)
Eye-drug developer Azura Ophthalmics, working from Melbourne and Tel Aviv, has assembled a seven-member scientific advisory board of ophthalmology specialists to guide clinical development of its lead candidate AZR-MD-001.